Currently out of the existing stock ratings of Dewey Steadman, 48 are a BUY (80%), 12 are a HOLD (20%).

Dewey Steadman

Work Performance Price Targets & Ratings Chart

Analyst Dewey Steadman, has had 52.12% of price targets met with an average potential upside of 24.89%, reached in 256 days on average. Previously, Dewey Steadman worked at CANACCORD, BAIRD.

Dewey Steadman has documented 117 price targets and ratings displayed on 13 stocks. The coverage was on Healthcare, Industrials sectors.

Most recent stock forecast was given on SVRA, Savara at 13-Jun-2019.

Wall Street Analyst Dewey Steadman

Analyst best performing recommendations are on INSM (INSMED).
The best stock recommendation documented was for PCRX (PACIRA PHARMACEUTICALS) on 2/15/2018. The price target of $32 was fulfilled within 1 day with a profit of $4.1 (11.36%), with a performance score of 113.57.

Average potential price target upside

AERI Aerie Pharmaceuticals ANIP ANI Pharmaceuticals ENDP Endo International PLC MNK Mallinckrodt plc PCRX Pacira Pharmaceuticals PRGO Perrigo Company PLC PRTK Paratek Pharmaceuticals INSM Insmed LPCN Lipocine SVRA Savara ACET Adicet Bio AER AerCap Holdings NV TLGT Teligent

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 19-Dec-2019

$15.25

$13

4 years 2 months 21 days ago
(29-Aug-2022)

2/7 (28.57%)

$0.18 (1.19%)

109

Buy Since 07-May-2020

$15.25

$29

4 years 2 months 26 days ago
(24-Aug-2022)

1/2 (50%)

$0.07 (0.46%)

47

Buy Since 16-Feb-2018

$20

4 years 2 months 26 days ago
(24-Aug-2022)

0/6 (0%)

$14.21 (245.42%)

Buy Since 19-Nov-2013

$15.25

$27

4 years 2 months 27 days ago
(23-Aug-2022)

10/14 (71.43%)

$0.09 (0.59%)

161

Buy Since 22-Oct-2019

$15.25

$30

4 years 2 months 27 days ago
(23-Aug-2022)

1/3 (33.33%)

$0.09 (0.59%)

48

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?